Approved Symbol |
Approved Name |
Location |
Source |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid) |
1p35 |
Mapped by PBA pathway |
PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q23-qter |
Mapped by PBA pathway |
PLA2G2E |
phospholipase A2, group IIE |
1p36.13 |
Mapped by PBA pathway |
PLA2G2D |
phospholipase A2, group IID |
1p36.12 |
Mapped by PBA pathway |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3p26.1 |
Mapped by CNV |
PLA2G4B |
phospholipase A2, group IVB (cytosolic) |
15q11.2-q21.3 |
Mapped by PBA pathway |
PLA2G3 |
phospholipase A2, group III |
22q12.2 |
Mapped by PBA pathway |
PLA2G5 |
phospholipase A2, group V |
1p36-p34 |
Mapped by PBA pathway |
PLCB2 |
phospholipase C, beta 2 |
15q15 |
Mapped by PBA pathway |
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
Mapped by PBA pathway |
MAPK1 |
mitogen-activated protein kinase 1 |
22q11.2 |
Mapped by LD-proxy |
CACNA1A |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
19p13 |
Mapped by PBA pathway |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
12p11.23 |
Mapped by LD-proxy; Mapped by literature SNP |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
11q23.1 |
Mapped by significant region |
GUCY1A2 |
guanylate cyclase 1, soluble, alpha 2 |
11q21-q22 |
Mapped by significant region |
MAPK3 |
mitogen-activated protein kinase 3 |
16p11.2 |
Mapped by CNV |
RYR1 |
ryanodine receptor 1 (skeletal) |
19q13.1 |
Mapped by PBA pathway |
PLA2G10 |
phospholipase A2, group X |
16p13.1-p12 |
Mapped by PBA pathway; Mapped by significant region |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
11q13 |
Mapped by significant region |